Journal of Alzheimer's Disease Reports · Nov 10, 2026
Dipeptidyl peptidase-4 inhibitors and slower dementia progression in patients with diabetes: A multicenter longitudinal cohort study
By Wang TY, Wang CC, Chang HT et al.
Background: Diabetes mellitus increases cognitive impairment and dementia risk. Although antidiabetic drugs are investigated for dementia prevention, their role in modifying established dementia progression remains insufficiently explored. Objective: We aimed to investigate the association between anti-diabetic drug classes and dementia progression. Methods: This retrospective longitudinal cohort study across three Taiwanese medical centers evaluated participants with dementia and type 2 diabetes (September 2015∼August 2022). Multivariable logistic regression and Cox proportional hazards models examined drug classes associations with dementia progression. Results: Among 1007 participants with dementia and diabetes, the progression group had a significantly higher mean age than the non-progression group (78.8 ± 7.8 versus 76.9 ± 9.4 years, p < 0.001). However, no significant difference in sex distribution was observed between the two groups, with females comprising 65.1% of the progression group and 63.8% of the non-progression group. Use of dipeptidyl peptidase-4 inhibitors (DPP-4i) was associated with a significantly lower risk of dementia progression compared with non-users (adjusted OR 0.52, 95% CI 0.33–0.82). Among individual DPP-4i, linagliptin demonstrated the strongest association with slower time-to-progression (adjusted OR 0.46, 95% CI 0.25–0.75; adjusted HR 0.64, 95% CI 0.44–0.94). Although all other DPP-4i showed a trend toward reduced progression, statistical significance was observed only for linagliptin. Conclusions: In this cohort of patients with dementia and diabetes, DPP-4i use was associated with a slower rate of dementia progression. Exploratory agent-specific analyses suggested an association between linagliptin use and a lower risk of progression; however, comparative effectiveness among individual DPP-4i could not be established.